Literature DB >> 24950960

Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation.

Paolo Pieragnoli1, Anna Maria Gori, Giuseppe Ricciardi, Gianmarco Carrassa, Luca Checchi, Antonio Michelucci, Raffaella Priora, Anna Paola Cellai, Rossella Marcucci, Luigi Padeletti, Rosanna Abbate.   

Abstract

Cryoablation (CA) emerged as an alternative procedure to radiofrequency (RF). The aim of this study was to compare haemostatic system alterations in patients undergoing RF or CA for atrioventricular nodal reentrant tachycardia ablation. von Willebrand factor (vWF), spontaneous whole blood platelet aggregation, prothrombin fragment F1 + 2 (F1 + 2), thrombin-antithrombin complex (TAT), plasminogen activator inhibitor type-1 (PAI-1), and clot lysis time (CLT) were determined in 48 patients (27 CA; 21 RF; 19M/29F, mean age 49.6 ± 17.6 years). Blood samples were obtained before the procedure (T0), immediately after (T1), and 24 h later (T2). At T1 both procedures were associated with a significant increase in levels of the endothelial activation marker vWF. At T2 vWF levels were lower in CA than in RF group. No changes in whole blood platelet aggregation before and after ablation procedures were observed. At T1 both groups determined an increase in blood clotting activation markers, F1 + 2, TAT, and DD. At T2 F1 + 2, TAT and DD levels were similar to baseline values. The comparison between RF and CA showed no significant differences in F1 + 2 and TAT levels, whereas at T1 DD levels were higher in CA group than in RF group. Both procedures induced a significant decrease in CLT, whereas no changes in PAI-1 levels were found. There were no significant differences in CLT and PAI-1 levels. The fibrinolytic efficiency analysis showed that at T1 DD/TAT and DD/F1 + 2 ratios were lower in RF group and remained lower in RF than in CA group at T2. CA procedure may be associated with a lower degree of endothelial damage and with a higher fibrinolytic capacity respect to RF.

Entities:  

Mesh:

Year:  2014        PMID: 24950960     DOI: 10.1007/s11739-014-1090-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  19 in total

Review 1.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society.

Authors:  Carina Blomström-Lundqvist; Melvin M Scheinman; Etienne M Aliot; Joseph S Alpert; Hugh Calkins; A John Camm; W Barton Campbell; David E Haines; Karl H Kuck; Bruce B Lerman; D Douglas Miller; Charlie Willard Shaeffer; William G Stevenson; Gordon F Tomaselli; Elliott M Antman; Sidney C Smith; Joseph S Alpert; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Richard O Russell; Silvia G Priori; Jean Jacques Blanc; Andzrej Budaj; Enrique Fernandez Burgos; Martin Cowie; Jaap Willem Deckers; Maria Angeles Alonso Garcia; Werner W Klein; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Carlos Araujo Morais; Ali Oto; Otto Smiseth; Hans Joachim Trappe
Journal:  J Am Coll Cardiol       Date:  2003-10-15       Impact factor: 24.094

2.  Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle.

Authors:  Frank A J L Scheer; Steven A Shea
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

3.  A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion.

Authors:  Anna Paola Cellai; Donatella Lami; Sandra Fedi; Rossella Marcucci; Lucia Mannini; Caterina Cenci; Angela Rogolino; Andrea Sodi; Ugo Menchini; Rosanna Abbate; Domenico Prisco
Journal:  Atherosclerosis       Date:  2012-07-03       Impact factor: 5.162

4.  Thrombogenicity of radiofrequency lesions: results with serial D-dimer determinations.

Authors:  A S Manolis; H Melita-Manolis; V Vassilikos; T Maounis; J Chiladakis; V Christopoulou-Cokkinou; D V Cokkinos
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

5.  Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation.

Authors:  Paul Khairy; Patrick Chauvet; John Lehmann; Jean Lambert; Laurent Macle; Jean-François Tanguay; Martin G Sirois; Domenic Santoianni; Marc Dubuc
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

6.  Hemostatic changes before and during electrophysiologic study and radiofrequency catheter ablation.

Authors:  Petr Parizek; L Haman; M Pleskot; M Pecka; J Bukac; P Stransky; J Maly
Journal:  Int J Hematol       Date:  2011-03-09       Impact factor: 2.490

Review 7.  Cryoablation versus radiofrequency ablation of atrioventricular nodal reentrant tachycardia.

Authors:  Pasquale Santangeli; Riccardo Proietti; Luigi Di Biase; Rong Bai; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2013-11-29       Impact factor: 1.900

8.  Evidence that fibrinolytic changes in paediatric obesity translate into a hypofibrinolytic state: relative contribution of TAFI and PAI-1.

Authors:  Fabrizio Semeraro; Paola Giordano; Maria F Faienza; Luciano Cavallo; Nicola Semeraro; Mario Colucci
Journal:  Thromb Haemost       Date:  2012-06-28       Impact factor: 5.249

9.  Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis.

Authors:  Ton Lisman; Philip G de Groot; Joost C M Meijers; Frits R Rosendaal
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

10.  Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.

Authors:  Rita Paniccia; Emilia Antonucci; Niccolò Maggini; Eloisa Romano; Anna Maria Gori; Rossella Marcucci; Domenico Prisco; Rosanna Abbate
Journal:  Am J Clin Pathol       Date:  2009-06       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.